Evidence map›Paper›PMID 37515491›Full record

ArticleJournal of comparative effectiveness research2023

Handling related publications reporting real-world evidence in network meta-analysis: a case study in multiple sclerosis.

Marissa Betts, Kyle Fahrbach, Binod Neupane, Mahmoud Slim, Maria Pia Sormani, Gary Cutter, Thomas Pa Debray, Marvin Rock

Open access · diamondAbstract read
In one paragraph

Article in Journal of comparative effectiveness research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Marissa BettsEvidera Inc., Waltham, MA 02451, USA.
Kyle FahrbachEvidera Inc., Waltham, MA 02451, USA.
Binod NeupaneEvidera Inc., Saint-Laurent, QC H4S 1V3, Canada.
Mahmoud SlimEvidera Inc., Saint-Laurent, QC H4S 1V3, Canada.ORCID 0000-0003-2455-1432
Maria Pia SormaniUniversity of Genoa, Department of Health Sciences, Genoa, Italy.ORCID 0000-0001-6892-104X
Gary CutterUniversity of Alabama at Birmingham, School of Public Health, Birmingham, AL, USA.ORCID 0000-0002-8455-980X
Thomas Pa DebrayUnversity Medical Center Utrecht, Utrecht, The Netherlands.ORCID 0000-0002-1790-2719
Marvin RockFormerly Biogen, Cambridge, MA 02142, USA.
Ithaka Harbors · USBiogen (United States) · USCentraal Bureau voor de Statistiek · NLUniversity of Alabama at Birmingham · USUniversity of Genoa · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Multiple SclerosisBayes TheoremHumansNetwork Meta-Analysis as TopicRecurrencedimethyl fumaratedisease-modifying therapiesmultiple sclerosisnetwork meta-analysisreal-world evidence

Identifiers

PMID37515491
PMCPMC10508334
OpenAlexW4385380344

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.